Projects

Mgr. Eva Horváthová, PhD.

National

Current
  • Role of DNA damage and repair in response of urogenital cancers to cisplatin-based chemotherapy
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Synthesis, physicochemical, biological properties of glycoconjugates, N-heterocycle-based precursors and polysaccharide derivatives as potential anticancer and antiviral agents
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Molecular mechanisms of trialkyl-/triaryltin isothiocyanates\' and carboxylates\' antitumour properties - novel ligands of nuclear retinoid X receptors in rat mammary gland carcinomas and human tumour cell lines
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • Interaction of bioactive compounds and non-thermal plasma
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Diglycosidases in biocatalysis
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2021
  • Turning cisplatin-resistant testiular germ cell tumors into a curable disease
    Program: SRDA
    Duration: 1. 8. 2018 – 31. 12. 2021
  • Unravelling the mechanisms of post-translational regulation of RNA splicing factors in maintenance of genome integrity
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
  • Novel synergistic antitumour properties ofnuclear retinoid X receptor (RXR) agonists as a consequence of the conditional RXR-RAR heterodimer formation in human breast cancer cells
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Study of protective potential of synthesized phenylethanoid glycosides in the systems of mammalian cells and plasmid DNA
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • The biological effects of the environment with reduced deuterium (D) content or increased pH and physical exercise in relation to cancer: implications for tertiary prevention.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2018
  • Chemoenzymatic synthesis and evaluation of biological activities of natural glycophenolics and their analogues
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Protective potential of plant extracts in experimental systems in vitro and ex vivo
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • DNA repair and preleukemic clones in cord blood stem cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Study of essential oils and their components from the point of view of the protective action in the initiation step of carcinogenesis; experimental systems in vitro and ex vivo
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
Employees